-Actin was run as an internal standard for equivalent loading. time profile of calpain activity exhibited substrate specificity. Fluoro-Jade B staining exposed an immediate neurodegenerative response that Tetrahydrobiopterin was in direct relationship to the period of anesthesia in the cortex and inversely related to the period of anesthesia in the thalamus. At later on post-treatment intervals, lifeless neurons were recognized only in the thalamus 24 h following a 6-hour propofol publicity. Strong caspase-3 manifestation that was recognized at 24 h was not followed by cell death after 2- and 4-hour exposures to propofol. These results revealed complex patterns Tetrahydrobiopterin of caspase-3 and calpain activities following prolonged propofol anesthesia and suggest that both are a manifestation of propofol neurotoxicity at a critical developmental stage. KEY PHRASES:Anesthesia-induced neurotoxicity, Apoptosis, Thalamus, Spectrin, Poly(ADP-ribose) polymerase 1, Protein kinase C, Neurodegeneration == Intro == General anesthetics that are widely Tetrahydrobiopterin used in medical practice can stimulate apoptotic cell death in the central nervous system of experimental animals when administered during synaptogenesis that occurs during the 1st 2 weeks of existence [1]. Anesthetics are regularly combined in order to accomplish adequate depth and period of anesthesia. However, studies in animals have revealed detrimental effects of these providers when they are used simultaneously, as compared to when they are applied on their own [2]. This imposes a necessity to elucidate the fundamental mechanisms of action and potential harmful effects of each anesthetic separately. Propofol (2,6-diisopropylphenol) is an alkyl phenol derivate that has gained wide clinical use for induction and maintenance of general anesthesia. The greatest characteristics of propofol are its pharmacokinetic properties that account for the clinical benefits of quick onset of anesthesia and a short recovery time. Concerning the mechanism of action, a number of experimental studies have shown that propofol potentiates GABAAreceptor functioning, while at higher concentrations, it causes opening of GABAAreceptors [3]. A study of the effects of propofol in developing animals suggests that propofol raises neurodegeneration that leads to subsequent behavioral and learning impairments [2,4]. Propofol-induced neurotoxicity depends on the concentration and duration of treatment, as demonstrated in in vitro studies, and on the dose, as exposed in in vivo studies in mice [2,5,6]. The cellular mechanisms and signaling pathways that underlie anesthesia-induced neurotoxicity are poorly recognized. Activation of caspase-3 appears to be induced by general anesthetics in postnatal brains during maturation [6,7,8]. Of the recognized caspases, caspase-3 stands out since it is definitely triggered by many cell death signals and cleaves a variety of important cellular proteins such as cytoskeletal proteins, kinases, and DNA repair enzymes [9]. Another protease that is involved in cell death is definitely calpain. It is likely that calpain is definitely activated by an initial insult via a rise in intracellular calcium from both extracellular and intracellular sources [10]. Under normal conditions, calpain activation is a controlled Tetrahydrobiopterin process that leads to a limited cleavage of substrates that have either regulatory or signaling functions. However, strong or prolonged calpain activity underlies the pathophysiology of a number of conditions. Calpain is generally associated with excitotoxic neuronal injury and necrosis, although evidence for a role in apoptotic cell death has been presented [11]. A growing body of literature has exposed the living of Mouse monoclonal to ALCAM functional contacts between the calpains and caspases in vitro and in vivo. The calpains have the potential to both positively and negatively modulate the caspase cascade during apoptosis. There is also evidence that caspases indirectly upregulate calpain activity by cleaving calpastatin, an endogenous calpain inhibitor [9]. While the involvement.